121
Participants
Start Date
June 30, 2012
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
Infliximab
Perfusion of IFX 5mg/kg to be increased to 10 mg/kg based on clinical symptoms
Infliximab
Perfusion of IFX 5mg/kg or 10 mg/kg if dose increase criteria are met (biological)
Infliximab
Perfusion of IFX 5mg/kg or 7,5 mg/kg if dose increase criteria are met (biological)and 10mg/kg if dose increase criteria are met for a second time
Chu Toulouse, Toulouse
CHU Bordeaux - Pessac, Pessac
Chu Rennes, Rennes
Chu Tours, Tours
Chu Reims, Reims
Chu Nancy, Vandœuvre-lès-Nancy
Chu Clermont-Ferrand, Clermont-Ferrand
Hopital Saint Louis, Paris
Chu Amiens, Amiens
Hopital Beaujon, Clichy
CHRU Lille, Lille
CHU NICE, Nice
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
OTHER